|
Volumn 20, Issue 4, 2006, Pages 524-525
|
Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: Effective prophylaxis against recurrence
|
Author keywords
Hepatitis B; Hepatitis B immune globulin; Immune globulin; Liver transplantation; Subcutaneous
|
Indexed keywords
ANTICOAGULANT AGENT;
BAY HEP B;
HEPARIN;
HEPATITIS B ANTIBODY;
HEPATITIS B SURFACE ANTIBODY;
HEPATOVIR;
LAMIVUDINE;
VIRUS DNA;
WARFARIN;
ADULT;
ANTIBODY TITER;
ARTICLE;
CASE REPORT;
CHRONIC HEPATITIS;
CONTINUOUS INFUSION;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
FEASIBILITY STUDY;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
INFECTION PREVENTION;
INTERNATIONAL NORMALIZED RATIO;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MAINTENANCE THERAPY;
MALE;
MULTIPLE DRUG DOSE;
PORTAL VEIN THROMBOSIS;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
RADIODIAGNOSIS;
RECURRENT VIRUS INFECTION;
SURGICAL TECHNIQUE;
THROMBECTOMY;
THROMBOCYTOPENIA;
THROMBOSIS PREVENTION;
TREATMENT DURATION;
TREATMENT OUTCOME;
ANTIVIRAL AGENTS;
HEPATITIS B;
HUMANS;
IMMUNIZATION, PASSIVE;
IMMUNOGLOBULINS;
LAMIVUDINE;
LIVER FAILURE, ACUTE;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
RECURRENCE;
|
EID: 33745601376
PISSN: 09020063
EISSN: 13990012
Source Type: Journal
DOI: 10.1111/j.1399-0012.2006.00517.x Document Type: Article |
Times cited : (22)
|
References (6)
|